(Q39620303)

13 September 2017

title

Development of a murine model of lymph node metastases suitable for immunotoxicity studies (English)

1 reference

13 September 2017

0 references

1 reference

Devon D Egenolf

1

1 reference

13 September 2017

Patricia Rafferty

2

1 reference

13 September 2017

Kerry Brosnan

3

1 reference

13 September 2017

Mindi Walker

4

1 reference

13 September 2017

Jarrat Jordan

5

1 reference

13 September 2017

Dorie Makropoulos

6

1 reference

13 September 2017

Karl Kavalkovich

7

1 reference

13 September 2017

Sharon Watson

8

1 reference

13 September 2017

Laura Johns

9

1 reference

13 September 2017

Amy Volk

10

1 reference

13 September 2017

Peter J Bugelski

11

1 reference

13 September 2017

publication date

13 December 2010

1 reference

Journal of Pharmacological and Toxicological Methods

13 September 2017

published in

1 reference

13 September 2017

volume

63

1 reference

13 September 2017

issue

3

1 reference

13 September 2017

page(s)

236-249

1 reference

Anti-tumor effect of an intratumoral administration of dendritic cells in combination with TS-1, an oral fluoropyrimidine anti-cancer drug, and OK-432, a streptococcal immunopotentiator: involvement of toll-like receptor 4.

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Noninvasive imaging of quantum dots in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Macrophage activation and innate resistance to infection in SCID mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Influence of host defenses on the hepatic colonization of B16F10 melanoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Control of autofluorescence of archival formaldehyde-fixed, paraffin-embedded tissue in confocal laser scanning microscopy (CLSM).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Rapamycin inhibits the growth and metastatic progression of non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Biological effects of cyclosporin A: A new antilymphocytic agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Rejection of an MHC class II negative tumor following induction of murine syngeneic graft-versus-host disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Cutting edge: cross-presentation as a mechanism for efficient recruitment of tumor-specific CTL to the brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

A proposal for a standardized system of reporting human lymph node morphology in relation to immunological function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Inhibition of NK cell activity through TGF-beta 1 by down-regulation of NKG2D in a murine model of head and neck cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

GFP expression alters osteosarcoma cell biology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

The facilitation of tumour growth in the lung by cyclophosphamide in artificial and spontaneous metastases models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Newer therapeutic approaches for systemic lupus erythematosus: immunosuppressive agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Cancer immunoediting: from immunosurveillance to tumor escape

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Effect of cyclosporin A on the growth and spontaneous metastasis of syngeneic animal tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Automated time-lapse microscopy and high-resolution tracking of cell migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

In vivo cancer targeting and imaging with semiconductor quantum dots

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Immunosurveillance and immunoregulation by gammadelta T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Regulation of cutaneous malignancy by gammadelta T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Host’s Immune State and Kinetics of Local Tumor Growth Control — Progression of Postoperative Lung Metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Spontaneous and induced primary oncogenesis in natural killer (NK)-cell-deficient beige mutant mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Calcineurin and the biological effect of cyclosporine and tacrolimus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Incomplete differentiation of antigen-specific CD8 T cells in tumor-draining lymph nodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Further studies of the relationship between lymphatic dissemination and lymphnodal metastasis in non-immunogenic murine tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Cellular and molecular mechanisms of tumor-induced T-cell tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Experiences with renal homotransplantation in the human: report of nine cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Augmentation of B16 melanoma lung colony formation in C57BL/6 mice having marked granulocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Quantum dots are phagocytized by macrophages and colocalize with experimental gliomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Vaccinations with dendritic cells primed with apoptotic tumor cells can elicit preventive antitumor immunity in a poorly immunogenic animal model of squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Sirolimus: a comprehensive review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Effects of cyclosporin A on the activation of natural killer T cells induced by alpha-galactosylceramide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Everolimus (RAD) inhibits in vivo growth of murine squamous cell carcinoma (SCC VII)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Characterization of a spontaneously arising murine squamous cell carcinoma (SCC VII) as a prerequisite for head and neck cancer immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

The effect of C3H mouse mammary tumour on the levels of serum and urine analytes in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Why do we not all die of cancer at an early age?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Adaptive immunity maintains occult cancer in an equilibrium state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

V(D)J recombination in peritoneal B cells of leaky scid mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Endogenous IL-17 contributes to reduced tumor growth and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Fibroblasts as efficient antigen-presenting cells in lymphoid organs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Effect of immunosuppressants on the expansion and function of naturally occurring regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Risk of nonmelanoma skin cancer with azathioprine use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

T helper 17 cells promote cytotoxic T cell activation in tumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Mechanisms of action of cyclosporine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Interleukin-27 activates natural killer cells and suppresses NK-resistant head and neck squamous cell carcinoma through inducing antibody-dependent cellular cytotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Quantum dots for live cells, in vivo imaging, and diagnostics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Concomitant development of granulocytosis and enhancement of metastases formation in tumor-bearing mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Real time in vivo non-invasive optical imaging using near-infrared fluorescent quantum dots.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Interleukin-12 gene therapy prevents establishment of SCC VII squamous cell carcinomas, inhibits tumor growth, and elicits long-term antitumor immunity in syngeneic C3H mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Interferon-gamma potentiates the antitumor effect of cyclosporine-induced autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

A new immunocompetent murine model for oral cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

State of academic knowledge on toxicity and biological fate of quantum dots

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

The immune system--is it relevant to cancer development, progression and treatment?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Extralymphatic tumors prepare draining lymph nodes to invasion via a T-cell cross-tolerance process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Cyclosporine-induced autoimmunity and immune hyperreactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Gene therapy for head and neck cancer using vaccinia virus expressing IL-2 in a murine model, with evidence of immune suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Experimental studies on the incidence of metastases after failure of radiation treatment and the effect of salvage surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Green fluorescent protein expression in dendritic cells enhances their immunogenicity and elicits specific cytotoxic T-cell responses in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Tumor signaling to the bone marrow changes the phenotype of monocytes and pulmonary macrophages during urethane-induced primary lung tumorigenesis in A/J mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Celecoxib can prevent tumor growth and distant metastasis in postoperative setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Early events of hepatic metastasis formation in mice: role of Kupffer and NK-cells in natural and interferon-gamma-stimulated defense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Immunosuppression and cancer: the ciclosporin case

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Analysis of metastatic spread and growth of tumor cells in mice with depressed natural killer activity by anti-asialo GM1 antibody or anticancer agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Role of natural killer activity in development of spontaneous metastases in murine renal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Role of arachidonic acid metabolites in tumor growth inhibition by nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Chediak-Higashi Syndrome: a rare disorder of lysosomes and lysosome related organelles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Differential tumor surveillance by natural killer (NK) and NKT cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

The effects of cyclosporin A on non-T cell components of the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Tumor necrosis factor antagonist mechanisms of action: a comprehensive review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Skin cancer in organ transplant recipients--where do we stand today?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Metastatic properties of murine sarcomas and carcinomas. I. Positive correlation with lung colonization and lack of correlation with s.c. tumor take

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

AsGM1+ NK cells prevent metastasis of invading LD-MCA-38 tumor cells in the nude mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Lighting up cells with quantum dots

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Calcineurin inhibitors and rapamycin: cancer protection or promotion?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Comparison of three cell fixation methods for high content analysis assays utilizing quantum dots

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Redundancy of direct priming and cross-priming in tumor-specific CD8+ T cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Angiogenesis inhibition by an oncolytic herpes virus expressing interleukin 12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

An activating immunoreceptor complex formed by NKG2D and DAP10

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Enhanced protection against fatal mycobacterial infection in SCID beige mice by reshaping innate immunity with IFN-gamma transgene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Complementary role of CD4+ T cells and secondary lymphoid tissues for cross-presentation of tumor antigen to CD8+ T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

Malignancy after solid organ transplantation: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

The SCID (severe combined immunodeficiency) mouse--its biology and use in immunotoxicological research.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.12.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VASCN.2010.12.001

1 reference

13 September 2017

1 reference